Stockscreener 앱 받기
3.10
0.32%
0.01
시간 외 거래:
3.03
-0.07
-2.26%
전일 마감가:
$3.09
열려 있는:
$3.03
하루 거래량:
358.27K
Relative Volume:
0.86
시가총액:
$43.32M
수익:
$12,000
순이익/손실:
$-48.50M
주가수익비율:
-0.1816
EPS:
-17.0687
순현금흐름:
$-19.78M
1주 성능:
+0.65%
1개월 성능:
-63.29%
6개월 성능:
-80.30%
1년 성능:
-88.00%
1일 변동 폭
$2.92
$3.14
1주일 범위
$2.85
$3.40
52주 변동 폭
$2.40
$49.80
Incannex Healthcare Inc Stock (IXHL) Company Profile
명칭
Incannex Healthcare Inc
전화
61 409 840 786
주소
8 CENTURY CIRCUIT, NORWEST NSW
Compare IXHL vs TAK, ZTS, HLN, TEVA, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IXHL
Incannex Healthcare Inc
|
3.10 | 43.18M | 12,000 | -48.50M | -19.78M | -17.07 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.11 | 56.96B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
115.99 | 49.54B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.23 | 45.90B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.44 | 34.48B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
527.00 | 23.24B | 3.18B | 1.33B | 1.04B | 27.90 |
Incannex Healthcare Inc 주식(IXHL)의 최신 뉴스
Incannex says it holds $75 million in cash with zero debt after financing - MSN
Incannex Highlights $75 Million Cash, No Debt, and Advances IHL-42X and PSX-001 Clinical Programs - Minichart
Incannex approves 1-for-30 reverse stock split to regain Nasdaq compliance - MSN
Incannex Healthcare Inc. (IXHL) implements 1-for-30 reverse split effective February 26 - MSN
Incannex reports $75M cash position with no debt after financing - Investing.com India
Incannex Healthcare Strengthens Cash Position, Highlights Clinical Pipeline - TipRanks
Incannex Highlights $75M Cash, No Debt as It Funds DReAMzz Phase 2 and Advances IHL-42X - TradingView
Incannex Highlights Strong Balance Sheet with Approximately $75 Million in Cash and No Debt as Company Advances IHL-42X Development - The Manila Times
Incannex (Nasdaq: IXHL) highlights $75M cash, no debt and advancing trials - Stock Titan
Market values Incannex at $46M despite $75M in cash - Stock Titan
Incannex regains Nasdaq compliance with minimum bid price By Investing.com - Investing.com India
Incannex Healthcare Regains Nasdaq Compliance and Advances Clinical Pipeline with Strong Cash Position - Minichart
Incannex regains Nasdaq compliance with minimum bid price - Investing.com
Incannex regains compliance with Nasdaq minimum bid price requirement - marketscreener.com
Incannex Regains Nasdaq Compliance, Strengthening Pipeline Progress - TipRanks
Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement - The Manila Times
Incannex Healthcare (NASDAQ: IXHL) restores Nasdaq bid price compliance, highlights $75M cash - Stock Titan
Biotech Incannex clears Nasdaq listing hurdle, holds $75M cash and no debt - Stock Titan
Incannex outlines dose-optimization study for sleep apnea treatment - MSN
Incannex Stock Slides As $10 Million Capital Raise Funds Next Study For Sleep Apnea Treatment - Yahoo Finance UK
Incannex Healthcare Announces $10 Million Direct Offering - The Globe and Mail
IXHL Stock Price, Quote & Chart | INCANNEX HEALTHCARE INC (NASDAQ:IXHL) - ChartMill
Dow Tumbles Over 1%; US Weekly Jobless Claims Fall - Sahm
Why did IXHL stock slump 20% in pre-market today? - MSN
Incannex plans dose-optimization study for sleep apnea drug By Investing.com - Investing.com South Africa
IHL.AX Incannex Healthcare (ASX) A$0.041 intraday 13 Mar 2026: Phase 2 news drives volume - Meyka
Incannex plans dose-optimization study for sleep apnea drug - Investing.com Australia
Incannex Healthcare (NASDAQ: IXHL) sells 1.997M units for ~$9M - Stock Titan
Will Incannex Healthcare Inc benefit from AI trends2026 Retail Activity & Low Risk High Win Rate Stock Picks - baoquankhu1.vn
Incannex Updates Clinical Pathway for Sleep Apnea Drug Candidate IHL-42X - Sleep Review
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Incannex Healthcare stock drops 20% after $10 mn private placement | Tap to know more | Inshorts - Inshorts
Incannex Strengthens Clinical Development Pathway for IHL-42X Following Positive Phase 2 Outcomes - Bitget
Why Did IXHL Stock Slump 20% In Pre-Market Today? - Asianet Newsable
Incannex prices 2M shares at $5.00 in registered direct offering - TipRanks
Incannex Healthcare prices $10M registered direct offering - MSN
Incannex announces enhanced development strategy for IHL-42X - TipRanks
Why Did IXHL Stock Slump 35% Today? - Stocktwits
Incannex Healthcare Inc Shares Drop 20% After $10 Million Placement Announcement - Intellectia AI
Incannex Highlights Enhanced Phase 2 Study and Updates - TipRanks
Incannex Healthcare Inc. (NASDAQ: IXHL) officially announced that the company has completed the pricing of a registered direct offering with a total size of 10 million dollars. - Bitget
Incannex Healthcare Inc. Announces Pricing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - The Manila Times
Incannex Healthcare (NASDAQ: IXHL) sets $10M direct stock and warrant offering - Stock Titan
Incannex $10M raise funds DReAMzz Phase 2 trial, preserves Phase 3 cash - Stock Titan
Sleep apnea pill from Incannex cut apnea events by up to 83% in trial - Stock Titan
IXHL Stock Rips To Best Day In 5 Months: Nasdaq Compliance Back In Sight As FDA Catalyst For Sleep Apnea Drug Looms - Stocktwits
Should I trade or invest in Incannex Healthcare IncEarnings Overview Summary & Daily Stock Trend Reports - baoquankhu1.vn
Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update - MarketBeat
Incannex Surges 720% On Sleep Apnea Trial Progress: ‘Penny Bio Pharma Mania’ Lifts Retail Sentiment - MSN
How Incannex Healthcare Inc. stock compares to market leadersJuly 2025 Spike Watch & Safe Capital Preservation Plans - Naître et grandir
Incannex Healthcare Inc (IXHL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.02%
0.77%
자본화:
|
볼륨(24시간):